Biotech giant Amgen is welcoming a familiar face to its C-suite after it was announced that Peter Griffith, who has served as the company’s executive vice president and CFO since 2020, will be retiring. Replacing him will be Thomas Dittrich, who will return to Amgen as executive vice president on July 1 and succeed Griffith…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
